Published in Clin Exp Vaccine Res on July 31, 2012
Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use. Clin Exp Vaccine Res (2014) 0.77
The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis. PLoS Negl Trop Dis (2016) 0.76
The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis. Virulence (2016) 0.75
Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine. PLoS One (2013) 0.75
Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines. Heliyon (2017) 0.75
Bacterial ghosts as adjuvants: mechanisms and potential. Vet Res (2017) 0.75
The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. J Antimicrob Chemother (2003) 2.52
Studies on the propagation in vitro of poliomyelitis viruses. I. Viral multiplications in tissue cultures employing monkey and human testicular cells. J Exp Med (1952) 2.26
Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A (2006) 2.23
Studies on the cultivation of poliomyelitis viruses in tissue culture. I. The propagation of poliomyelitis viruses in suspended cell cultures of various human tissues. J Immunol (1952) 2.07
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol (1993) 1.92
Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol (1991) 1.60
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine (2001) 1.56
Differentiation of a Vero cell adapted porcine epidemic diarrhea virus from Korean field strains by restriction fragment length polymorphism analysis of ORF 3. Vaccine (2003) 1.47
Current status of veterinary vaccines. Clin Microbiol Rev (2007) 1.44
Surface-displayed viral antigens on Salmonella carrier vaccine. Nat Biotechnol (2000) 1.38
Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol (2006) 1.31
A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine (1994) 1.21
Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol (2000) 1.07
H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine (2011) 1.06
A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J Gen Virol (1994) 1.05
Growth and attenuation of rabies virus in cell cultures of reptilian origin. Proc Soc Exp Biol Med (1972) 1.04
Diva vaccines that reduce virus transmission. J Biotechnol (1999) 1.03
Mucosal delivery of vaccines in domestic animals. Vet Res (2006) 1.01
Virus-like particles: the new frontier of vaccines for animal viral infections. Vet Immunol Immunopathol (2012) 1.00
Immunogenicity of a Salmonella Enteritidis mutant as vaccine candidate and its protective efficacy against salmonellosis in chickens. Vet Immunol Immunopathol (2011) 1.00
Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine (2011) 0.99
Differentiation of serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J Gen Virol (1986) 0.99
Evaluation of safety and protection efficacy on cpxR and lon deleted mutant of Salmonella Gallinarum as a live vaccine candidate for fowl typhoid. Vaccine (2010) 0.98
Nasal vaccination using live bacterial vectors. Adv Drug Deliv Rev (2001) 0.96
Virus-like particles: designing an effective AIDS vaccine. Methods (2006) 0.94
Classical swine fever (hog cholera): review of aspects relevant to control. Transbound Emerg Dis (2011) 0.93
Live bacterial delivery systems for development of mucosal vaccines. Curr Opin Mol Ther (2000) 0.91
A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine (2002) 0.91
Virus-like particles: potential veterinary vaccine immunogens. Res Vet Sci (2011) 0.89
Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice. J Vet Sci (2005) 0.89
Outer membrane protein H for protective immunity against Pasteurella multocida. J Microbiol (2007) 0.88
Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2005) 0.88
Immune responses to new vaccine candidates constructed by a live attenuated Salmonella Typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model. J Vet Med Sci (2011) 0.88
Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy. Influenza Other Respir Viruses (2012) 0.87
Recent pre-harvest supplementation strategies to reduce carriage and shedding of zoonotic enteric bacterial pathogens in food animals. Anim Health Res Rev (2004) 0.86
Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines. Vet Microbiol (2004) 0.84
Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. J Control Release (1998) 0.84
Immunization of pregnant sows with a novel virulence gene deleted live Salmonella vaccine and protection of their suckling piglets against salmonellosis. Vet Microbiol (2009) 0.84
Immune response induced by ppGpp-defective Salmonella enterica serovar Gallinarum in chickens. J Microbiol (2010) 0.84
Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2. Vet Microbiol (2011) 0.83
Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins. J Vet Sci (2008) 0.82
Efficacy of a novel virulence gene-deleted Salmonella Typhimurium vaccine for protection against Salmonella infections in growing piglets. Vet Immunol Immunopathol (2010) 0.82
Increased virulence of an infectious bursal disease live virus vaccine after passage in chicks. Vaccine (1985) 0.81
Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus. Res Vet Sci (2010) 0.81
Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine. Immunol Lett (2008) 0.80
Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch Virol (1992) 0.80
Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA. Vaccine (2007) 0.80
Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine. Vaccine (2002) 0.80
Protective immunity of microsphere-based mucosal vaccines against lethal intranasal challenge with Streptococcus pneumoniae. Infect Immun (1999) 0.80
Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice. Vaccine (2010) 0.79
Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus. Exp Mol Med (2008) 0.79
Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism. Adv Drug Deliv Rev (2005) 0.79
Oral administration of Salmonella enterica serovar Typhimurium expressing swine interleukin-18 induces Th1-biased protective immunity against inactivated vaccine of pseudorabies virus. Vet Microbiol (2011) 0.79
Induction of immune responses to glycoprotein gD of Aujeszky's disease virus with DNA immunization. J Vet Med Sci (2001) 0.78
Antigenicity of partial fragments of recombinant Pasteurella multocida toxin. J Microbiol Biotechnol (2010) 0.78
Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus. Mol Biotechnol (2009) 0.78
Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice. Immune Netw (2009) 0.78
Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine. Vaccine (2011) 0.78
Lactobacillus acidophilus expressing recombinant K99 adhesive fimbriae has an inhibitory effect on adhesion of enterotoxigenic Escherichia coli. Microbiol Immunol (2005) 0.78
Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1. Vector Borne Zoonotic Dis (2012) 0.78
FDA aims to curb farm use of antibiotics. JAMA (2012) 0.77
Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus. Comp Immunol Microbiol Infect Dis (2011) 0.77
Characterization of the recombinant proteins of porcine circovirus type2 field isolate expressed in the baculovirus system. J Vet Sci (2002) 0.77
Veterinary vaccines for public health and prevention of viral and bacterial zoonotic diseases. Rev Sci Tech (2007) 0.76
The application of food safety interventions in primary production of beef and lamb: a review. Int J Food Microbiol (2010) 0.76
The Vaccination History of Small-Pox Cases. Br Med J (1902) 0.76
A novel vaccine combined with an alum adjuvant for porcine encephalomyocarditis virus (EMCV)-induced reproductive failure in pregnant sows. Res Vet Sci (2012) 0.76
Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer (2007) 1.22
The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur J Immunol (2006) 1.20
DNA barcoding techniques for avian influenza virus surveillance in migratory bird habitats. J Wildl Dis (2010) 1.20
Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol (2006) 1.17
Nationwide groundwater surveillance of noroviruses in South Korea, 2008. Appl Environ Microbiol (2010) 1.09
Evidence of intercontinental transfer of North American lineage avian influenza virus into Korea. Infect Genet Evol (2010) 1.06
H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine (2011) 1.06
Molecular epidemiology of rabies virus isolates from South Korea. Virus Res (2005) 1.05
Inhaled hydrogen gas therapy for prevention of testicular ischemia/reperfusion injury in rats. J Pediatr Surg (2012) 1.03
H9N2 avian influenza virus in Korea: evolution and vaccination. Clin Exp Vaccine Res (2013) 1.03
Continuing evolution and interspecies transmission of influenza viruses in live bird markets in Korea. Avian Dis (2010) 1.02
Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res (2011) 0.98
Analysis of complete genome sequences of swine hepatitis E virus and possible risk factors for transmission of HEV to humans in Korea. J Med Virol (2010) 0.97
Immune responses and pathogenesis in immunocompromised chickens in response to infection with the H9N2 low pathogenic avian influenza virus. Virus Res (2008) 0.97
Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo. Exp Cell Res (2006) 0.96
Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus. Virus Res (2012) 0.96
An emerging recombinant cluster of nephropathogenic strains of avian infectious bronchitis virus in Korea. Infect Genet Evol (2011) 0.95
Serological responses after vaccination of growing pigs with foot-and-mouth disease trivalent (type O, A and Asia1) vaccine. Vet Microbiol (2013) 0.93
Exchange of Newcastle disease viruses in Korea: the relatedness of isolates between wild birds, live bird markets, poultry farms and neighboring countries. Infect Genet Evol (2011) 0.93
Fast duplex one-step reverse transcriptase PCR for rapid differential detection of West Nile and Japanese encephalitis viruses. J Clin Microbiol (2010) 0.93
Severe canine influenza in dogs correlates with hyperchemokinemia and high viral load. Virology (2011) 0.92
Experimental infection and natural contact exposure of ferrets with canine influenza virus (H3N2). J Gen Virol (2013) 0.92
Surveillance and isolation of HPAI H5N1 from wild Mandarin Ducks (Aix galericulata). J Wildl Dis (2011) 0.91
Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus. Arch Virol (2013) 0.90
Microarray analysis of differential expression of cell cycle and cell differentiation genes in cells infected with Lawsonia intracellularis. Vet J (2009) 0.89
Effect of Adeli suit treatment on gait in a child with cerebral palsy: a single-subject report. Physiother Theory Pract (2014) 0.88
Isolation of Lawsonia intracellularis in Korea and reproduction of proliferative enteropathy in pigs and hamsters. J Vet Med Sci (2006) 0.88
Highly Pathogenic Avian Influenza A(H5N8) Viruses Reintroduced into South Korea by Migratory Waterfowl, 2014-2015. Emerg Infect Dis (2016) 0.88
Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy. Influenza Other Respir Viruses (2012) 0.87
Isolation and characterization of a novel H9N2 influenza virus in Korean native chicken farm. Avian Dis (2011) 0.87
Development of RNA aptamers for detection of Salmonella Enteritidis. J Microbiol Methods (2012) 0.87
Prevalence, antibiotic resistance, and molecular characterization of Salmonella serovars in retail meat products. J Food Prot (2011) 0.86
Examining the effects of remote monitoring systems on activation, self-care, and quality of life in older patients with chronic heart failure. J Cardiovasc Nurs (2014) 0.86
Rumpel-Leede phenomenon associated with noninvasive blood pressure monitoring -A case report-. Korean J Anesthesiol (2010) 0.84
Surveillance for West Nile virus in dead wild birds, South Korea, 2005-2008. Emerg Infect Dis (2011) 0.84
Antiviral effect of flavonol glycosides isolated from the leaf of Zanthoxylum piperitum on influenza virus. J Microbiol (2014) 0.83
Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets. Vaccine (2013) 0.83
Comparative measurement of cell-mediated immune responses of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus. Clin Vaccine Immunol (2010) 0.83
Ethnic and language disparities in diabetes care among California residents. Ethn Dis (2011) 0.83
Virus-like particle vaccine protects against H3N2 canine influenza virus in dog. Vaccine (2013) 0.82
Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins. J Vet Sci (2008) 0.82
Determination of fecal shedding rates and genotypes of swine hepatitis E virus (HEV) in Korea. J Vet Med Sci (2008) 0.82